Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/08/2005WO2005115426A1 Drug for ameliorating male climacteric disorder
12/08/2005WO2005115421A1 Use of a compound comprising d-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
12/08/2005WO2005115417A2 Polycationic antimicrobial therapeutic
12/08/2005WO2005115413A1 Rain-fast bioactive compositions
12/08/2005WO2005115412A2 Compositions and methods for modulating an immune response
12/08/2005WO2005115411A1 Agent for visualizing transparent tissue
12/08/2005WO2005115410A2 Context dependent inhibitors of cytidine deaminases and uses thereof
12/08/2005WO2005115409A1 Composition for inhibiting the onset of arteriosclerosis and inhibition method
12/08/2005WO2005115408A1 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
12/08/2005WO2005115407A2 Calmodulin independent activation of nitric oxide synthase
12/08/2005WO2005115406A2 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
12/08/2005WO2005115405A1 Methods for treating or preventing restenosis and other vascular proliferative disorders
12/08/2005WO2005115404A1 Combination of salts of o-acetyl salicylic acid and alpha-glucosidase inhibitors
12/08/2005WO2005115403A2 Induction of innate immunity by vitamin d3 and its analogs
12/08/2005WO2005115402A1 Use of a combination of ethinyl estradiol and chlormadinone acetate for the production of a medicament
12/08/2005WO2005115401A1 Method of preparing a latanoprost ophthalmic solution and solution thus produced
12/08/2005WO2005115400A2 Antibiotic compound
12/08/2005WO2005115399A2 Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
12/08/2005WO2005115398A2 Hiv integrase inhibitors
12/08/2005WO2005115397A2 Compositions and treatments for modulating kinase and/or hmg-coa reductase
12/08/2005WO2005115396A2 Combination of atomoxetine and a 5t1a receptor agonist for treating adhd and other disorders
12/08/2005WO2005115395A2 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
12/08/2005WO2005115394A2 Prenyl-electrostatic switch, and methods of use
12/08/2005WO2005115393A1 An anti-hyperlipemia composition
12/08/2005WO2005115392A2 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005WO2005115391A1 Method for treating abnormal cell growth
12/08/2005WO2005115390A2 Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses
12/08/2005WO2005115389A2 Specific ppar agonists for treating negative energy balance
12/08/2005WO2005115388A1 A therapeutic agent containing nicotinic acid or its derivatives as an effective ingredient for prevention and treatment of cancer
12/08/2005WO2005115387A1 Sustained release composition for oral administration of niacin
12/08/2005WO2005115386A1 Liquid preparation for veterinary medicine, method for the production thereof, and use of the same
12/08/2005WO2005115385A1 Use of c-kit inhibitors for treating acne
12/08/2005WO2005115384A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
12/08/2005WO2005115383A2 Substituted triazoles as modulators of ppar and methods of their preparation
12/08/2005WO2005115382A1 Crth2 receptor ligands for medicinal uses
12/08/2005WO2005115381A2 COMPOSITION CONTAINING POLICOSANOL AND HMG-Co-A REDUCTASE INHIBITOR AND THEIR PHARMACEUTICAL USES
12/08/2005WO2005115380A2 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
12/08/2005WO2005115379A2 Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
12/08/2005WO2005115378A1 Compositions comprising flavonoids and tocotrienols and methods thereof
12/08/2005WO2005115377A1 Functional foods comprising flavonoids and tocotrienols and methods thereof
12/08/2005WO2005115376A1 Pharmaceutical products for treating neoplastic disease and inflammation
12/08/2005WO2005115375A1 Oculoselective drugs and prodrugs
12/08/2005WO2005115374A1 Crth2 receptor ligands for therapeutic use
12/08/2005WO2005115373A1 Use of neboglamine (cr 2249) as an antipsychotic and neuroprotective
12/08/2005WO2005115372A1 Decreasing brain neuronal glutamate levels using alpha-keto branched chain amino acids
12/08/2005WO2005115371A1 Pharmaceutical compositions for the prevention and treatment of atherosclerosis
12/08/2005WO2005115370A2 Compounds and methods for treating non-inflammatory pain using pparalpha agonists
12/08/2005WO2005115369A2 Use of ppar agonists to treat ruminants
12/08/2005WO2005115368A1 Carrier composition for topical formulations
12/08/2005WO2005115367A2 Modulation of neurotransmitter activity in neurons
12/08/2005WO2005115366A1 Agent for preventing/amelioratig life style-relaetd diseases containing turmeric essential oil component
12/08/2005WO2005115365A2 Pharmaceutical or cosmetic composition comprising mequinol and at least one depigmenting agent
12/08/2005WO2005115364A1 Antitumor agent
12/08/2005WO2005115363A2 Method for treating skeletal disorders resulting from fgfr malfunction
12/08/2005WO2005115362A1 Treating seizures using ice inhibitors
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005WO2005115360A2 Formulations of anti-pain agents and methods of using the same
12/08/2005WO2005115359A2 Methods and compositions for the treatment of uveitis
12/08/2005WO2005115358A2 Intranasal delivery of nucleic acid molecules
12/08/2005WO2005115357A2 Taurolidine formulations and delivery
12/08/2005WO2005115355A1 Pasting preparation
12/08/2005WO2005115351A1 Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate
12/08/2005WO2005115350A1 Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate
12/08/2005WO2005115349A1 Folic acid-containing contraceptive
12/08/2005WO2005115347A1 Dispersible tablet comprising beta lactam antibiotics and process for preparing the same
12/08/2005WO2005115346A2 Pharmaceutical composition containing risperidone
12/08/2005WO2005115344A1 Oral delivery system
12/08/2005WO2005115336A2 Sprayable formulations for the treatment of acute inflammatory skin conditions
12/08/2005WO2005115335A1 Spot-on formulation useful for cosmetology and dermatology
12/08/2005WO2005115333A2 A biomolecule-containing formulation of increased stability
12/08/2005WO2005115332A2 Heat sterilization of glucocorticosteroids
12/08/2005WO2005115324A1 Dermatological composition for the treatment of pigmentary disorders of the skin
12/08/2005WO2005115323A1 Mequinol-based dermatological depigmenting composition
12/08/2005WO2005115317A1 Association of chlorin p6 with polyvinylpyrrolidone, a process for its preparation and its uses
12/08/2005WO2005115175A1 Food compositions containing creatine
12/08/2005WO2005115172A1 Oral and/or topical compositions comprising prebiotics and fatty acid
12/08/2005WO2005115171A1 Oral and/or topical compositions comprising prebiotics and sterols
12/08/2005WO2005115170A1 Oral and /or topical compositions
12/08/2005WO2005101982A3 A stable ophthalmic composition
12/08/2005WO2005099713A3 Novel antiviral pharmaceutical composition
12/08/2005WO2005097757A3 Nucleoside derivatives and therapeutic use thereof
12/08/2005WO2005097191A3 COMBINATIONS COMPRISING (S)- AMLODIPINE AND A HMG-CoA REDUCTASE INHIBITOR OR CHOLESTEROL ABSORPOTION INHIBITOR OR BOTH, AND METHODS FOR REDUCING HYPERTENSION
12/08/2005WO2005097100A3 Antibacterial agents
12/08/2005WO2005092039A3 Crosslinked amine polymers
12/08/2005WO2005091754A3 Novel cyclopentenedione antifungal compounds and methods for their use
12/08/2005WO2005089751A3 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation
12/08/2005WO2005089737A3 Materials and methods for inhibiting wip1
12/08/2005WO2005089736A3 Methods for treating inflammatory and autoimmune diseases
12/08/2005WO2005089294A3 Synthesis of indenoisoquinoliniums and methods of use
12/08/2005WO2005087724A3 Sulphonylpyrroles as hdac inhibitors
12/08/2005WO2005085196A3 Inhibitors of dna methylation in tumor cells
12/08/2005WO2005084695A3 Use of carboxypeptidase g for combating antifolate toxicity
12/08/2005WO2005084652A3 Use of antagonists of the cb1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
12/08/2005WO2005084610A3 New therapeutic use for a group of sulphated polysaccharides
12/08/2005WO2005082860A8 Tetracyclines and their use as calpain inhibitors
12/08/2005WO2005082350A8 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
12/08/2005WO2005081649A3 Preparation for reducing protein deficiency in an organism and method for the production thereof
12/08/2005WO2005080549A3 Trioxacarcins and their use against infections
12/08/2005WO2005079852A3 Bacteriostatic esters for topical use
12/08/2005WO2005079827A3 Antitumor agent
1 ... 4439 4440 4441 4442 4443 4444 4445 4446 4447 4448 4449 4450 4451 4452 4453 4454 4455 4456 4457 4458 4459 ... 7860